Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-27 Scadden David Director Grant or award · Stock option (right to buy) +16,000 16,000
2017-05-25 Cantley Lewis Clayton Jr. Director Sale −509 $46.92 $24K 90,697
2017-05-25 Cantley Lewis Clayton Jr. Director Sale −509 $46.92 $24K 90,737
2017-05-24 Cantley Lewis Clayton Jr. Director Sale −509 $47.27 $24K 91,206
2017-05-24 Cantley Lewis Clayton Jr. Director Sale −509 $47.27 $24K 91,246
2017-05-01 Schenkein David P Chief Executive Officer Option exercise +3,000 $0.30 $908 3,000
2017-05-01 Schenkein David P Chief Executive Officer Sale −3,000 $50.06 $150K 0
2017-05-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −3,000 192,656
2017-04-24 Celgene European Investment Co LLC 10% owner Purchase +624,575 $49.50 $30.9M 1,856,353
2017-04-18 Cantley Lewis Clayton Jr. Director Sale −509 $50.92 $26K 91,715
2017-04-18 Cantley Lewis Clayton Jr. Director Sale −509 $50.92 $26K 91,755
2017-04-17 Cantley Lewis Clayton Jr. Director Sale −509 $55.13 $28K 93,751
2017-04-17 Cantley Lewis Clayton Jr. Director Sale −509 $55.13 $28K 93,791
2017-04-17 Cantley Lewis Clayton Jr. Director Sale −1,527 $55.27 $84K 92,224
2017-04-17 Cantley Lewis Clayton Jr. Director Sale −1,527 $55.27 $84K 92,264
2017-04-03 Biller Scott Chief Scientific Officer Option exercise +2,146 $9.05 $19K 17,880
2017-04-03 Biller Scott Chief Scientific Officer Sale −2,146 $58.03 $125K 15,734
2017-04-03 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −2,146 46,011
2017-04-03 Schenkein David P Chief Executive Officer Option exercise +3,000 $0.30 $908 3,000
2017-04-03 Schenkein David P Chief Executive Officer Sale −3,000 $58.62 $176K 0

Page 76 of 80 · 1,590 trades